Connor, Clark & Lunn Investment Management (CC&L)’s Mirum Pharmaceuticals MIRM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $21.6M | Buy |
|
|||||
|
2025
Q1 | $16.1M | Buy |
|
|||||
|
2024
Q4 | $7.32M | Buy |
|
|||||
|
2024
Q3 | $2.63M | Buy |
|
|||||
|
2024
Q2 | $1.57M | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $3.94M | Buy |
|
|||||
|
2023
Q3 | $3.61M | Buy |
|
|||||
|
2023
Q2 | $976K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $225K | Sell |
|
|||||
|
2022
Q2 | $282K | Sell |
|
|||||
|
2022
Q1 | $507K | Sell |
|
|||||
|
2021
Q4 | $409K | Buy |
|